What is the impact of hypogammaglobulinemia on the rate of infections and survival in solid organ transplantation? A meta-analysis

American Journal of Transplantation

Volumn 13, Issue 10, 2013, Pages 2601-2610

  Florescu, D F ^a   Kalil, A C ^a   Qiu, F ^a   Schmidt, C M ^b   Sandkovsky, U ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Cytomegalovirus; fungal; hypogammaglobulinemia; infection; respiratory infections

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; DACLIZUMAB; IMMUNOGLOBULIN G; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ALLOGRAFT; ARTICLE; CARDIAC GRAFT REJECTION; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE SEVERITY; GRAFT RECIPIENT; HEART GRAFT; HUMAN; IMMUNOGLOBULIN DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RATE; INVASIVE ASPERGILLOSIS; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; LIVER GRAFT; LIVER GRAFT REJECTION; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; META ANALYSIS; MORTALITY; MYCOSIS; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SURVIVAL RATE; SYSTEMATIC REVIEW; URINARY TRACT INFECTION;

CYTOMEGALOVIRUS; FUNGAL; HYPOGAMMAGLOBULINEMIA; INFECTION; RESPIRATORY INFECTIONS;

AGAMMAGLOBULINEMIA; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; OPPORTUNISTIC INFECTIONS; ORGAN TRANSPLANTATION; PROGNOSIS; RISK FACTORS; SURVIVAL RATE;

EID: 84884907165     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12401     Document Type: Article

References (43)

1. Mawhorter S, Yamani MH., Hypogammaglobulinemia and infection risk in solid organ transplant recipients. Curr Opin Organ Transplant 2008; 13: 581-585.
2. Jordan SC, Toyoda M, Kahwaji J, Vo AA., Clinical aspects of intravenous immunoglobulin use in solid organ transplant recipients. Am J Transplant 2011; 11: 196-202.
3. Carbone J, Sarmiento E, Palomo J, et al. The potential impact of substitutive therapy with intravenous immunoglobulin on the outcome of heart transplant recipients with infections. Transplant Proc 2007; 39: 2385-2388.
4. Goldfarb NS, Avery RK, Goormastic M, et al. Hypogammaglobulinemia in lung transplant recipients. Transplantation 2001; 71: 242-246.
5. Sarmiento E, Rodriguez-Molina J, Munoz P, et al. Decreased levels of serum immunoglobulins as a risk factor for infection after heart transplantation. Transplant Proc 2005; 37: 4046-4049.
6. Broeders EN, Wissing KM, Hazzan M, et al. Evolution of immunoglobulin and mannose binding protein levels after renal transplantation: Association with infectious complications. Transpl Int 2008; 21: 57-64.
7. Doron S, Ruthazer R, Werner BG, Rabson A, Snydman DR., Hypogammaglobulinemia in liver transplant recipients: Incidence, timing, risk factors, and outcomes. Transplantation 2006; 81: 697-703.
8. Keven K, Sahin M, Kutlay S, et al. Immunoglobulin deficiency in kidney allograft recipients: Comparative effects of mycophenolate mofetil and azathioprine. Transpl Infect Dis 2003; 5: 181-186.
9. Carbone J, Micheloud D, Salcedo M, et al. Humoral and cellular immune monitoring might be useful to identify liver transplant recipients at risk for development of infection. Transpl Infect Dis 2008; 10: 396-402.
10. Fernandez-Ruiz M, Lopez-Medrano F, Varela-Pena P, et al. Monitoring of immunoglobulin levels identifies kidney transplant recipients at high risk of infection. Am J Transplant 2012; 12: 2763-2773.
11. Sarmiento E, Rodriguez-Molina JJ, Fernandez-Yanez J, et al. IgG monitoring to identify the risk for development of infection in heart transplant recipients. Transpl Infect Dis 2006; 8: 49-53.
12. Viechtbauer W., Conducting meta-analyses in R with the metafor package. J Stat Softw 2010; 36: 1-48.
13. DerSimonian R, Laird N., Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
14. Hozo SP, Djulbegovic B, Hozo I., Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005; 5: 13.
15. Gregorek H, Jankowska I, Dzierzanowska-Fangrat K, et al. Long-term monitoring of Epstein-Barr virus DNA load and humoral parameter abnormalities in pediatric liver transplant recipients before development of malignancy. Pediatr Transplant 2010; 14: 629-635.
16. Kawut SM, Shah L, Wilt JS, et al. Risk factors and outcomes of hypogammaglobulinemia after lung transplantation. Transplantation 2005; 79: 1723-1726.
17. Ku G, Varghese Z, Fernando ON, Baillod R, Hopewell JP, Moorhead JF., Serum IgG and renal transplantation. Br Med J 1973; 4: 702-707.
18. Munoz P, Giannella M, Alcala L, et al. Clostridium difficile-associated diarrhea in heart transplant recipients: Is hypogammaglobulinemia the answer ? J Heart Lung Transplant 2007; 26: 907-914.
19. Pollock CA, Mahony JF, Ibels LS, et al. Immunoglobulin abnormalities in renal transplant recipients. Transplantation 1989; 47: 952-956.
20. Robertson J, Elidemir O, Saz EU, et al. Hypogammaglobulinemia: Incidence, risk factors, and outcomes following pediatric lung transplantation. Pediatr Transplant 2009; 13: 754-759.
21. Sarmiento E, Lanio N, Gallego A, et al. Immune monitoring of anti cytomegalovirus antibodies and risk of cytomegalovirus disease in heart transplantation. Int Immunopharmacol 2009; 9: 649-652.
22. Staak A, Renner F, Suesal C, et al. Immunoglobulin induction therapy in renal transplant recipients: Effects on immunoglobulin and regulatory antibody levels. Transplant Proc 2006; 38: 3483-3485.
23. Vaughan PJ, Nelson LA, Fuller CR., Humoral immunity and severe cytomegalovirus syndrome: A comparison of the effects of antilymphocyte globulin and cyclosporine on the IgG subclass distribution and CMV titers of renal transplant recipients. Transplant Proc 1985; 17: 154-160.
24. Yamani MH, Avery R, Mawhorter S, et al. Hypogammaglobulinemia after heart transplantation: Impact of pre-emptive use of immunoglobulin replacement (CytoGam) on infection and rejection outcomes. Transpl Infect Dis 2001; 3 (Suppl 2): 40-43.
25. Yamani MH, Avery R, Mawhorter SD, et al. The impact of CytoGam on cardiac transplant recipients with moderate hypogammaglobulinemia: A randomized single-center study. J Heart Lung Transplant 2005; 24: 1766-1769.
26. Yip NH, Lederer DJ, Kawut SM, et al. Immunoglobulin G levels before and after lung transplantation. Am J Respir Crit Care Med 2006; 173: 917-921.
27. Rong PB, Kalsi J, Hodgson HJ., Hyperglobulinaemia in chronic liver disease: Relationships between in vitro immunoglobulin synthesis, short lived suppressor cell activity and serum immunoglobulin levels. Clin Exp Immunol 1984; 55: 546-552.
28. Zuberi SJ, Siddiqui M, Lodi TZ., Immunoglobulins in liver disease. J Pak Med Assoc 1977; 27: 391-392.
29. Kawano T, Matsuse H, Obase Y, et al. Hypogammaglobulinemia in steroid-dependent asthmatics correlates with the daily dose of oral prednisolone. Int Arch Allergy Immunol 2002; 128: 240-243.
30. Klaustermeyer WB, Gianos ME, Kurohara ML, Dao HT, Heiner DC., IgG subclass deficiency associated with corticosteroids in obstructive lung disease. Chest 1992; 102: 1137-1142.
31. O'Keeffe S, Gzel A, Drury R, Cullina M, Greally J, Finnegan P., Immunoglobulin G subclasses and spirometry in patients with chronic obstructive pulmonary disease. Eur Respir J 1991; 4: 932-936.
32. Kroemer G, Martinez C., Pharmacological inhibition of programmed lymphocyte death. Immunol Today 1994; 15: 235-242.
33. Sackstein R, Borenstein M., The effects of corticosteroids on lymphocyte recirculation in humans: Analysis of the mechanism of impaired lymphocyte migration to lymph node following methylprednisolone administration. J Investig Med 1995; 43: 68-77.
34. Mathiesen T, Brattstrom C, Andersson J, Linde A, Ljungman P, Wahren B., Immunoglobulin G subclasses and lymphocyte stimulatory responses to cytomegalovirus in transplant patients with primary cytomegalovirus infections. J Med Virol 1992; 36: 65-69.
35. Siber GR, Schur PH, Aisenberg AC, Weitzman SA, Schiffman G., Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens. N Engl J Med 1980; 303: 178-182.
36. Spinsanti LI, Farias AA, Aguilar JJ, del Pilar Diaz M, Contigiani MS., Immunoglobulin G subclasses in antibody responses to St. Louis encephalitis virus infections. Arch Virol 2011; 156: 1861-1864.
37. Tarzi MD, Grigoriadou S, Carr SB, Kuitert LM, Longhurst HJ., Clinical immunology review series: An approach to the management of pulmonary disease in primary antibody deficiency. Clin Exp Immunol 2009; 155: 147-155.
38. Marr KA, Koudadoust M, Black M, Balajee SA., Early events in macrophage killing of Aspergillus fumigatus conidia: New flow cytometric viability assay. Clin Diagn Lab Immunol 2001; 8: 1240-1247.
39. Kontoyiannis DP, Georgiadou SP, Wierda WG, et al. Impaired bactericidal but not fungicidal activity of polymorphonuclear neutrophils in patients with chronic lymphocytic leukemia. Leuk Lymphoma 2012 [Epub ahead of print].
40. Joassin L, Somze A, Reginster M., Detection by enzyme-linked immunosorbent assay of specific immunoglobulin G isotypes in primary and established cytomegalovirus infections. J Clin Microbiol 1989; 27: 139-144.
41. Florescu DF, Islam KM, Sudan D, Mercer DF, Freifeld AG., Outcome in pediatric small bowel transplantation. 27th European Society of Pediatric Infectious Diseases Meeting, Brussels, Belgium, 2009.
42. Orange JS, Grossman WJ, Navickis RJ, Wilkes MM., Impact of trough IgG on pneumonia incidence in primary immunodeficiency: A meta-analysis of clinical studies. Clin Immunol 2010; 137: 21-30.
43. Nelson RP Jr., Ballow M., 26. Immunomodulation and immunotherapy: Drugs, cytokines, cytokine receptors, and antibodies. J Allergy Clin Immunol 2003; 111 (2 Suppl): S720-S743.